Helle Westergren Hendel

Helle Westergren Hendel

Clinical Associate Professor

Member of:

  • Clinical Physiology and Nuclear Medicine


Publication year:
All
1 - 10 out of 45Page size: 10
  1. 2023
  2. Published

    ASO Visual Abstract: Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma-A National Cohort Study of 1480 Patients

    Helvind, N. M., Weitemeyer, M. B. M., Chakera, A. H., Hendel, Helle Westergren, Ellebæk, E., Svane, Inge Marie, Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, Christoffer, Bidstrup, P. E. & Hølmich, Lisbet Rosenkrantz, 2023, In: Annals of Surgical Oncology. 30, 4, p. 2389-2390 2 p.

    Research output: Contribution to journal › Conference abstract in journal › Research

  3. Published

    Earlier Recurrence Detection Using Routine FDG PET-CT Scans in Surveillance of Stage IIB to IIID Melanoma: A National Cohort Study of 1480 Patients

    Helvind, N. M., Weitemeyer, M. B. M., Chakera, A. H., Hendel, Helle Westergren, Ellebæk, E., Svane, Inge Marie, Kjærskov, M. W., Bojesen, S., Skyum, H., Petersen, S. K., Bastholt, L., Johansen, Christoffer, Bidstrup, P. E. & Hølmich, Lisbet Rosenkrantz, 2023, In: Annals of Surgical Oncology. 30, 4, p. 2377-2388 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Randomised phase II trial of stereotactic body radiotherapy in combination with checkpoint inhibitors in metastatic castration-resistant prostate cancer (CheckPRO): a study protocol

    Spindler, N. J., Persson, Gitte F., Theile, S., Nielsen, D. L., Høgdall, Estrid Vilma Solyom, Al-Farra, G., Hendel, Helle Westergren, Lorentzen, T., Svane, Inge Marie, Lindberg, H. & Eefsen, R. L., 2023, In: BMJ Open. 13, 1, 8 p., e063500.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. 2022
  6. Published

    Clinical value of routine [18F]2-fluoro-2-deoxy-d-glucose positron emission tomography scans as a decision tool for early immunotherapy discontinuation in advanced melanoma

    Ellebaek, E., Schina, A., Andersen, R., Hendel, Helle Westergren, Svane, Inge Marie & dqp123, dqp123, 2022, In: International Journal of Cancer. 150, 11, p. 1870-1878 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Den gode beskrivelse og multidisciplinært team (MDT)

    Hjorthaug, K., Loft, A., Hendel, Helle Westergren, Andersen, T. B., Nellemann, H. M. & Lerberg Nielsen, A., 2022, Klinisk Nuklearmedicin. 3 ed. Munksgaard , p. 305-308

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

  8. Published

    Fine needle and core needle ultrasound guided biopsies for assessing suspected melanoma metastasis in lymph nodes and subcutaneous tissue

    Salim, D. N., Obinah, M. P. B., Ternov, N. K., McCullagh, M. J. D., Larsen, M. S., Hendel, Helle Westergren, Hølmich, Lisbet Rosenkrantz & Chakera, A. H., 2022, In: Journal of Surgical Oncology. 126, 6, p. 1058-1066 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Hud, blod og lymfesystem

    Hendel, Helle Westergren, Chakera, A. H., Svane, Inge Marie, Pedersen, Lars Møller, Oturai, P. S., Jensen, M. R. & Glenthøj, Andreas Birkedal, 2022, Klinisk Nuklearmedicin. Munksgaard , p. 187-220

    Research output: Chapter in Book/Report/Conference proceeding › Book chapter › Communication

  10. Published

    Observer experience and accuracy of F-18-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer

    Zacho, H. D., Ravn, S., Ejlersen, J. A., Fledelius, J., Dolliner, P., Nygaard, S. T., Holdgaard, P. C., Lauridsen, J. F., Nielsen, Christian E. Haarmark, Hendel, Helle Westergren & Petersen, L. J., 2022, In: Nuclear Medicine Communications. 43, 6, p. 680-686 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  11. 2021
  12. Published

    A phase 1/2 trial of an immune-modulatory vaccine against IDO/PD-L1 in combination with nivolumab in metastatic melanoma

    Kjeldsen, J. W., Lorentzen, C. L., Martinenaite, E., Ellebaek, E., dqp123, dqp123, Holmstroem, R. B., Klausen, T. W., Madsen, C. O., Ahmed, S. M., Weis-Banke, S. E., Holmström, M. O., Hendel, Helle Westergren, Ehrnrooth, E., Zocca, M. B., Pedersen, A. W., Andersen, Mads Hald & Svane, Inge Marie, 2021, In: Nature Medicine. 27, p. pages2212–2223

    Research output: Contribution to journal › Journal article › Research › peer-review

  13. Published

    Clinical efficacy of T-cell therapy after short-term BRAF-inhibitor priming in patients with checkpoint inhibitor-resistant metastatic melanoma

    Borch, T. H., Harbst, K., Rana, A. H., Andersen, R., Martinenaite, E., Kongsted, P., Pedersen, M., Nielsen, M., Kjeldsen, J. W., Kverneland, Anders Handrup, Lauss, M., Hølmich, Lisbet Rosenkrantz, Hendel, Helle Westergren, Met, Özcan, Jönsson, G., dqp123, dqp123 & Svane, Inge Marie, 2021, In: Journal for ImmunoTherapy of Cancer. 9, 7, 15 p., e00270.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 Next

ID: 916568